GlassScriptPhysician profile
Britton J Goodman
NPI 1821522608
$10,811.99
in general payments reported to CMS, 2019-2025
50 companies · $1,940 in 2025
The $1,940 reported for 2025 was more than what 95% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20.61 · 2020: $639 · 2021: $2,005 · 2022: $2,351 · 2023: $1,957 · 2024: $1,899 · 2025: $1,940.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,796.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,796.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,110.05 | 2021-2025 | |
| Lilly USA, LLC | $874.24 | 2020-2025 | Mounjaro, Jardiance, Zepbound |
| Astrazeneca Pharmaceuticals LP | $851.72 | 2020-2025 | Farxiga, Breztri, Airsupra |
| Glaxosmithkline, LLC. | $731.09 | 2020-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Abbott Laboratories | $709.09 | 2021-2025 | Freestyle Libre 3, Proclaim, Freestyle Libre 2 |
| Amgen INC. | $701.50 | 2020-2025 | Repatha, Otezla, Otezla |
| Novo Nordisk INC | $635.99 | 2020-2025 | Ozempic, Rybelsus, Wegovy |
| Bayer Healthcare Pharmaceuticals INC. | $602.96 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $535.01 | 2019-2024 | Jardiance |
| Pfizer INC. | $493.73 | 2020-2025 | |
| Sanofi-Aventis U.S. LLC | $391.72 | 2020-2025 | |
| Janssen Pharmaceuticals, INC | $355.69 | 2020-2023 | Xarelto |
| Merck Sharp & Dohme LLC | $257.44 | 2020-2025 | Gardasil 9, Belsomra, Steglatro |
| Lucid Diagnostics INC. | $230.52 | 2021-2023 | |
| Biohaven Pharmaceuticals, INC. | $187.02 | 2021 |
Show all 50 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Britton Goodman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.